Lumentum Holdings Inc. — Form 10-Q Summary
Reporting period: Fiscal third quarter ended April 1, 2023, with nine-month results compared with the periods ended April 2, 2022. Although the request metadata says “2022 Q3,” the filing covers fiscal 2023 Q3.
Business context
Lumentum sells optical communications and commercial laser products. In August 2022, it completed the NeoPhotonics merger and acquired IPG Photonics’ telecom transmission product lines; current-period results include those businesses after their acquisition dates. NeoPhotonics contributed $73.0 million of Q3 revenue and $250.4 million for the nine months. The company reports Optical Communications (OpComms) and Commercial Lasers (Lasers) segments.
Key financial results
| Metric | Q3 FY2023 | Q3 FY2022 | Nine months FY2023 | Nine months FY2022 |
|---|---|---|---|---|
| Revenue | $383.4 million | $395.4 million | $1,396.2 million | $1,290.5 million |
| Gross profit / margin | $112.0 million / 29.2% | $167.2 million / 42.3% | $479.4 million / 34.3% | $606.9 million / 47.0% |
| Operating income (loss) | $(51.4) million | $46.8 million | $(59.8) million | $247.9 million |
| Net income (loss) | $(39.3) million | $26.0 million | $(71.4) million | $164.2 million |
| Diluted EPS | $(0.57) | $0.35 | $(1.05) | $2.19 |
| Operating cash flow | Not separately stated for quarter | Not separately stated for quarter | $130.6 million | $345.0 million |
Q3 revenue fell 3.0% year over year; nine-month revenue rose 8.2%, partly reflecting acquisitions and improved ability to meet demand versus the prior-year supply constraints. Q3 operating expenses were $163.4 million, including $85.4 million of R&D, $76.4 million of SG&A, and $1.6 million of restructuring charges. Q3 interest expense was $8.7 million and other income was $11.4 million. The Q3 tax benefit was $9.4 million; the nine-month tax provision was $14.4 million.
Segment trends: Q3 OpComms revenue was $335.1 million, down 2.6%; Lasers revenue was $48.3 million, down 5.7%. OpComms gross margin was 40.8%, compared with 49.0%; Lasers gross margin was 40.4%, compared with 52.9%. For the nine months, OpComms revenue rose 7.8% and Lasers revenue rose 11.2%.
Liquidity, debt and capital resources
- At April 1, 2023, cash and cash equivalents were $549.2 million and short-term investments were $1,118.0 million, totaling $1,667.2 million, versus $2,549.0 million at July 2, 2022.
- Current assets were $2,463.6 million and current liabilities $768.9 million. Cash declined by $741.0 million over the nine months.
- Convertible-note carrying value totaled $2,327.0 million: $426.2 million due in 2024, $1,045.6 million due in 2026, and $855.2 million due in 2028. The 2024 Notes are current liabilities and have $448.1 million aggregate principal outstanding.
- Nine-month cash used in investing activities was $803.1 million, including $861.6 million net cash paid for acquisitions and $92.2 million of capital expenditures. Financing activities used $68.5 million.
- Management said cash, cash flows from operations, and available resources should cover liquidity and capital spending needs for at least the next 12 months.
Material changes and management commentary
- Q3 OpComms Telecom and Datacom revenue increased, including acquired NeoPhotonics revenue, but Datacom demand weakened amid customer inventory reduction and slower cloud data-center spending. Industrial and Consumer revenue declined $58.9 million, reflecting competition and share normalization. Lasers revenue was lower due mainly to reduced demand for kilowatt-class fiber lasers.
- Gross margin pressure reflected product mix, lower sales of higher-margin imaging and sensing products, acquired telecom products, excess and obsolete inventory charges, acquisition-related amortization, and higher-cost components sourced through brokers.
- Management said component supply would remain a challenge through the remainder of fiscal 2023. Customer ordering was difficult to predict as customers reduced inventories; one network equipment manufacturer deferred shipments originally expected in Q3. Incremental supply and procurement costs included in inventory were $10.8 million.
- Management expects to continue significant R&D investment despite weaker macroeconomic conditions. The filing provides no numerical revenue or earnings guidance.
- The company recorded $24.8 million of restructuring charges for the nine months, primarily for integration, cost reductions, and employee-related costs. It also wrote off $11.5 million of acquired in-process R&D projects it no longer planned to pursue.
- On April 5, 2023, after quarter-end, the board increased the share repurchase authorization to $1.2 billion through May 2025. No shares were repurchased during Q3; $25.7 million was spent during the nine-month period.
Risks and contingencies
- Key risks include customer inventory reductions and capital-spending weakness, concentrated customers, semiconductor and supplier constraints, competition and pricing pressure, acquisition integration, and exposure to export controls, tariffs, and geopolitical uncertainty.
- The company depends on a limited number of suppliers and contract manufacturers; purchase obligations were $379.2 million, generally expected to be fulfilled within one year.
- Unrecognized tax benefits were $50.4 million. Management could not reliably estimate timing of related future payments.
- A $7.8 million accrual was recorded for pending settlement of certain non-ordinary-course litigation matters. In the Oclaro merger-related Karri lawsuit, the court declined preliminary approval of the proposed settlement on April 20, 2023 and requested a revised motion. NeoPhotonics merger lawsuits had been dismissed.
- Management reported disclosure controls were effective. Acquired businesses were still being integrated into internal controls.
Important facts for investors to verify
- Whether customer inventory normalization and slower cloud spending continue to weigh on OpComms demand, and whether deferred shipments resume.
- Whether supply constraints, procurement costs, inventory write-downs, and product mix continue to pressure gross margins.
- Progress integrating NeoPhotonics and IPG product lines, including realization of expected benefits and final acquisition accounting.
- The company’s ability to address the $448.1 million principal maturity of the 2024 Notes in March 2024, and potential cash or dilution effects from convertible notes.
- Cash conversion and working-capital trends, particularly inventory growth and the decline in operating cash flow versus the prior-year period.
- Developments in the Karri litigation settlement and the company’s $7.8 million litigation accrual.